HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: Novel versatile preclinical models of human T cell responses

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 583-593

  Boucherma, Rachid ^a   Kridane Miledi, Hédia ^a   Bouziat, Romain ^a   Rasmussen, Michael ^b   Gatard, Tanja ^c   Langa Vives, Francina ^d   Lemercier, Brigitte ^d   Lim, Annick ^d   Bérard, Marion ^d   BenMohamed, Lbachir ^e   Buus, Søren ^b   Rooke, Ronald ^c   Lemonnier, François A ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TRANSGENE S A   (France)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; OLIGONUCLEOTIDE; PEPTIDE VACCINE; THREONYLPROLYLPROLYLALANYLTYROSYLARGINYLPROLYLPROLYLASPARAGINYLALANYLPROLYLISOLEUCYLLEUCINE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; HLA A*01:03 ANTIGEN; HLA A*24:02 ANTIGEN; HLA A1 ANTIGEN; HLA A24 ANTIGEN; HLA B*08:01 ANTIGEN; HLA B*27:05 ANTIGEN; HLA B*35:01 ANTIGEN; HLA B27 ANTIGEN; HLA B35 ANTIGEN; HLA B44 ANTIGEN; HLA B8 ANTIGEN; HLA-A*01:03 ANTIGEN; HLA-A*24:02 ANTIGEN; HLA-B*08:01 ANTIGEN; HLA-B*27:05 ANTIGEN; HLA-B*35:01 ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DNA IMMUNIZATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; GENETIC LINKAGE; HLA SYSTEM; LEUKOCYTE FUNCTION; MOUSE; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; ANIMAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CD4+ T LYMPHOCYTE; FEMALE; GENE; GENETICS; HUMAN; IMMUNOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, MHC CLASS I; HLA-A1 ANTIGEN; HLA-A24 ANTIGEN; HLA-B27 ANTIGEN; HLA-B35 ANTIGEN; HLA-B44 ANTIGEN; HLA-B8 ANTIGEN; HLA-C ANTIGENS; HUMANS; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL;

EID: 84880098430     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300483     Document Type: Article

References (86)

1. Pascolo, S. 2005. HLA class I transgenic mice: development, utilisation and improvement. Expert Opin. Biol. Ther. 5: 919-938. (Pubitemid 41032849)
2. Cardinaud, S., A. Moris, M. Février, P. S. Rohrlich, L. Weiss, P. Langlade-Demoyen, F. A. Lemonnier, O. Schwartz, and A. Habel. 2004. Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J. Exp. Med. 199: 1053-1063. (Pubitemid 38619902)
3. Szpak, Y., J.-C. Vieville, T. Tabary, M.-C. Naud, M. Chopin, C. Edelson, J. H. M. Cohen, J. Dausset, Y. de Kozak, and M. Pla. 2001. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc. Natl. Acad. Sci. USA 98: 2572-2576. (Pubitemid 32209523)
4. Toma, A., T. Laïka, S. Haddouk, S. Luce, J. P. Briand, L. Camoin, F. Connan, M. Lambert, S. Caillat-Zucman, J. C. Carel, et al. 2009. Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes. Diabetes 58: 394-402.
5. Visseren, M. J. W., S. H. van der Burg, E. I. H. van der Voort, R. M. P. Brandt, P. I. Schrier, P. van der Bruggen, T. Boon, C. J. M. Melief, andW. M. Kast. 1997. Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumorspecific MAGE-2 gene product. Int. J. Cancer 73: 125-130. (Pubitemid 27447024)
6. Ishioka, G. Y., J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. F. del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, et al. 1999. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162: 3915-3925. (Pubitemid 29314770)
7. Tourdot, S., A. Scardino, E. Saloustrou, D. A. Gross, S. Pascolo, P. Cordopatis, F. A. Lemonnier, and K. Kosmatopoulos. 2000. A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur. J. Immunol. 30: 3411-3421. (Pubitemid 32005212)
8. Dill, O., F. Kievits, S. Koch, P. Ivanyi, and G. J. Hämmerling. 1988. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc. Natl. Acad. Sci. USA 85: 5664-5668.
9. Kievits, F., P. Ivanyi, P. Krimpenfort, A. Berns, and H. L. Ploegh. 1987. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329: 447-449. (Pubitemid 17128315)
10. Kievits, F., W. J. Boerenkamp, W. Lokhorst, and P. Ivanyi. 1990. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition. J. Immunol. 144: 4513-4519. (Pubitemid 20224079)
11. Barra, C., B. Pérarnau, P. Gerlinger, M. Lemeur, A. Gillet, P. Gibier, and F. A. Lemonnier. 1989. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice. J. Immunol. 143: 3117-3124. (Pubitemid 20010135)
12. Epstein, H., R. Hardy, J. S. May, M. H. Johnson, and N. Holmes. 1989. Expression and function of HLA-A2.1 in transgenic mice. Eur. J. Immunol. 19: 1575-1583. (Pubitemid 19243874)
13. Le, A. X., E. J. Bernhard, M. J. Holterman, S. Strub, P. Parham, E. Lacy, and V. H. Engelhard. 1989. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142: 1366-1371. (Pubitemid 19067513)
14. Connolly, J. M., T. A. Potter, E. M. Wormstall, and T. H. Hansen. 1988. The Lyt-2 molecule recognizes residues in the class I alpha 3 domain in allogeneic cytotoxic T cell responses. J. Exp. Med. 168: 325-341.
15. Engelhard, V. H., E. Lacy, and J. P. Ridge. 1991. Influenza A-specific, HLA-A2.1- restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. J. Immunol. 146: 1226-1232.
16. Irwin, M. J., W. R. Heath, and L. A. Sherman. 1989. Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. J. Exp. Med. 170: 1091-1101. (Pubitemid 19250681)
17. Kalinke, U., B. Arnold, and G. J. Hämmerling. 1990. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27. Nature 348: 642-644. (Pubitemid 120015127)
18. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173: 1007-1015.
19. Alexander, J., C. Oseroff, J. Sidney, P. Wentworth, E. Keogh, G. Hermanson, F. V. Chisari, R. T. Kubo, H. M. Grey, and A. Sette. 1997. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J. Immunol. 159: 4753-4761. (Pubitemid 127471010)
20. Borenstein, S. H., J. Graham, X. L. Zhang, and J. W. Chamberlain. 2000. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens. J. Immunol. 165: 2341-2353. (Pubitemid 30660675)
21. Gotoh, M., H. Takasu, K. Harada, and T. Yamaoka. 2002. Development of HLAA2402/K(b) transgenic mice. Int. J. Cancer 100: 565-570.
22. Bharadwaj, M., M. Sherritt, R. Khanna, and D. J. Moss. 2001. Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine 19: 3769-3777. (Pubitemid 32522776)
23. LaFace, D. M., M. Vestberg, Y. Yang, R. Srivastava, J. DiSanto, N. Flomenberg, S. Brown, L. A. Sherman, and P. A. Peterson. 1995. Human CD8 transgene regulation of HLA recognition by murine T cells. J. Exp. Med. 182: 1315-1325.
24. Barra, C., H. Gournier, Z. Garcia, P. N. Marche, E. Jouvin-Marche, P. Briand, P. Fillipi, and F. A. Lemonnier. 1993. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice. J. Immunol. 150: 3681-3689. (Pubitemid 23129749)
25. + T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29: 1243-1252.
26. Cheuk, E., C. D'Souza, N. Hu, Y. Liu, H. Lang, and J. W. Chamberlain. 2002. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes. J. Immunol. 169: 5571-5580. (Pubitemid 35291656)
27. Rohrlich, P. S., S. Cardinaud, H. Firat, M. Lamari, P. Briand, N. Escriou, and F. A. Lemonnier. 2003. HLA-B*0702 transgenic, H-2KbDb double-knockout mice: phenotypical and functional characterization in response to influenza virus. Int. Immunol. 15: 765-772. (Pubitemid 36675807)
28. Laouini, D., A. Casrouge, S. Dalle, F. Lemonnier, P. Kourilsky, and J. Kanellopoulos. 2000. V b T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. J. Immunol. 165: 6381-6386.
29. Bouwer, H. G., M. S. Seaman, J. Forman, and D. J. Hinrichs. 1997. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J. Immunol. 159: 2795-2801. (Pubitemid 127681300)
30. Pascolo, S., N. Bervas, J. M. Ure, A. G. Smith, F. A. Lemonnier, and B. Pérarnau. 1997. HLA-A2.1-restricted education and cytolytic activity of CD8 (+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med. 185: 2043-2051. (Pubitemid 27265987)
31. Allen, H., J. Fraser, D. Flyer, S. Calvin, and R. Flavell. 1986. b 2-microglobulin is not required for cell surface expression of the murine class I histocompatibility antigen H-2Db or of a truncated H-2Db. Proc. Natl. Acad. Sci. USA 83: 7447-7451. (Pubitemid 16000539)
32. Bix, M., and D. Raulet. 1992. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. J. Exp. Med. 176: 829-834.
33. Glas, R., L. Franksson, C. Ohlén, P. Höglund, B. Koller, H. G. Ljunggren, and K. Kärre. 1992. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 89: 11381-11385.
34. Zijlstra, M., M. Bix, N. E. Simister, J. M. Loring, D. H. Raulet, and R. Jaenisch.1990. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 344: 742-746.
35. Joyce, S., K. Kuzushima, G. Kepecs, R. H. Angeletti, and S. G. Nathenson. 1994. Characterization of an incompletely assembled major histocompatibility class I molecule (H-2Kb) associated with unusually long peptides: implications for antigen processing and presentation. Proc. Natl. Acad. Sci. USA 91: 4145-4149.
36. Machold, R. P., S. Andrée, L. Van Kaer, H. G. Ljunggren, and H. L. Ploegh.1995. Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains. J. Exp. Med. 181: 1111-1122.
37. Schell, T. D., L. M. Mylin, S. S. Tevethia, and S. Joyce. 2002. The assembly of functional beta(2)-microglobulin-free MHC class I molecules that interact with peptides and CD8(+) T lymphocytes. Int. Immunol. 14: 775-782. (Pubitemid 34814638)
38. Gallez-Hawkins, G., M. C. Villacres, X. Li, M. C. Sanborn, N. A. Lomeli, and J. A. Zaia. 2003. Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response. J. Virol. 77: 4457-4462.
39. Ramage, J. M., R. Metheringham, R. Moss, I. Spendlove, R. Rees, and L. G. Durrant. 2004. Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice. Vaccine 22: 1728-1731. (Pubitemid 38447221)
40. Grigoriadou, K., C. Ménard, B. Pérarnau, and F. A. Lemonnier. 1999. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur. J. Immunol. 29: 3683-3690. (Pubitemid 29527817)
41. Lim, A., V. Baron, L. Ferradini, M. Bonneville, P. Kourilsky, and C. Pannetier. 2002. Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J. Immunol. Methods 261: 177-194. (Pubitemid 34175227)
42. Bouvier, I., H. Jusforgues-Saklani, A. Lim, F. Lemaitre, B. Lemercier, C. Auriau, M.-A. Nicola, S. Leroy, H.K. Law, A. Bandeira, et al. 2011. Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery. Front. Immunol. 2: 71.
43. Le Borgne, S., M. Mancini, R. Le Grand, M. Schleef, D. Dormont, P. Tiollais, Y. Rivière, and M.-L. Michel. 1998. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240: 304-315. (Pubitemid 28384237)
44. Harndahl, M., M. Rasmussen, G. Roder, and S. Buus. 2011. Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. J. Immunol. Methods 374: 5-12.
45. Mintz, B., and M. Bradl. 1991. Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat color pattern in transgenic homozygotes. Proc. Natl. Acad. Sci. USA 88: 9643-9647. (Pubitemid 21915687)
46. DiBrino, M., T. Tsuchida, R. V. Turner, K. C. Parker, J. E. Coligan, and W. E. Biddison. 1993. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151: 5930-5935. (Pubitemid 23340338)
47. Traversari, C., P. van der Bruggen, I. F. Luescher, C. Lurquin, P. Chomez, A. Van Pel, E. De Plaen, A. Amar-Costesec, and T. Boon. 1992. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176: 1453-1457.
48. Dai, L. C., K. West, R. Littaua, K. Takahashi, and F. A. Ennis. 1992. Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes. J. Virol. 66: 3151-3154.
49. Ikeda-Moore, Y., H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol. 159: 6242-6252. (Pubitemid 127471566)
50. Autran, B., and N. L. Letvin. 1991. HIV epitopes recognized by cytotoxic T-lymphocytes. AIDS 5(Suppl. 2): S145-S150.
51. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69: 4872-4879.
52. Jing, L., T. M. Chong, C. L. McClurkan, J. Huang, B. T. Story, and D. M. Koelle. 2005. Diversity in the acute CD8 T cell response to vaccinia virus in humans. J. Immunol. 175: 7550-7559. (Pubitemid 41713454)
53. Tussey, L. G., S. Rowland-Jones, T. S. Zheng, M. J. Androlewicz, P. Cresswell, J. A. Frelinger, and A. J. McMichael. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3: 65-77.
54. Brooks, J. M., R. J. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein- Barr virus peptide. J. Exp. Med. 178: 879-887. (Pubitemid 23260425)
55. Ibe, M., T. Sakaguchi, K. Tanaka, S. Saito, S. Yokota, T. Tanaka, K. Shimotohno, Y. Chujoh, Y. Shiratori, M. Omata, et al. 1998. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis. J. Gen. Virol. 79: 1735-1744. (Pubitemid 28330678)
56. Livingston, P. G., I. Kurane, L. C. Dai, Y. Okamoto, C. J. Lai, R. Men, S. Karaki, M. Takiguchi, and F. A. Ennis. 1995. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154: 1287-1295.
57. Burrows, S. R., I. S. Misko, T. B. Sculley, C. Schmidt, and D. J. Moss. 1990. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J. Virol. 64: 3974-3976. (Pubitemid 20227223)
58. DiBrino, M., K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1995. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry 34: 10130-10138.
59. Redchenko, I., R. Harrop, M. G. Ryan, R. E. Hawkins, and M. W. Carroll. 2006. Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4. Immunology 118: 50-57.
60. Breckpot, K., C. Heirman, C. De Greef, P. van der Bruggen, and K. Thielemans. 2004. Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses. J. Immunol. 172: 2232-2237. (Pubitemid 38182371)
61. Larrieu, P., V. Renaud, Y. Godet, F. Jotereau, and J.-F. Fonteneau. 2008. A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes. Cancer Immunol. Immunother. 57: 745-752.
62. Hoof, I., B. Peters, J. Sidney, L. E. Pedersen, A. Sette, O. Lund, S. Buus, and M. Nielsen. 2009. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
63. Dionne, S. O., D. F. Lake, W. J. Grimes, and M. H. Smith. 2004. Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries. Immunogenetics 56: 391-398. (Pubitemid 39349881)
64. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8a(a) and HLA-A2. Nature 387: 630-634. (Pubitemid 27248771)
65. Kern, P. S., M.-K. Teng, A. Smolyar, J.-H. Liu, J. Liu, R. E. Hussey, R. Spoerl, H. C. Chang, E. L. Reinherz, and J. H. Wang. 1998. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity 9: 519-530. (Pubitemid 28499203)
66. Sun, J., D. J. Leahy, and P. B. Kavathas. 1995. Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I. J. Exp. Med. 182: 1275-1280.
67. Feeney, A. J. 2009. Genetic and epigenetic control of V gene rearrangement frequency. Adv. Exp. Med. Biol. 650: 73-81.
68. Rudolph, M. G., and I. A. Wilson. 2002. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14: 52-65. (Pubitemid 34085107)
69. Sim, B. C., L. Zerva, M. I. Greene, and N. R. Gascoigne. 1996. Control of MHC restriction by TCR Valpha CDR1 and CDR2. Science 273: 963-966. (Pubitemid 26275174)
70. Torres-Nagel, N., B. Mehling, A. F. LeRolle, E. Joly, and T. Hünig. 2001. Genetic control of peripheral TCRAV usage by representation in the preselection repertoire and MHC allele-specific overselection. Int. Immunol. 13: 63-73. (Pubitemid 32060978)
71. Sesma, L., I. Alvarez, M. Marcilla, A. Paradela, and J. A. López de Castro. 2003. Species-specific differences in proteasomal processing and tapasin-mediated loading influence peptide presentation by HLA-B27 in murine cells. J. Biol. Chem. 278: 46461-46472. (Pubitemid 37452218)
72. Maier, R., K. Falk, O. Rötzschke, B. Maier, V. Gnau, S. Stevanović, G. Jung, H. G. Rammensee, and A. Meyerhans. 1994. Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40: 306-308. (Pubitemid 24275666)
73. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353: 326-329. (Pubitemid 21912497)
74. Saveanu, L., O. Carroll, V. Lindo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697. (Pubitemid 41716742)
75. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
76. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herberg, A. G. Grandea, S. R. Riddell, R. Tampé, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277: 1306-1309. (Pubitemid 27449083)
77. Sesma, L., B. Galocha, M. Vázquez, A. W. Purcell, M. Marcilla, J. McCluskey, and J. A. López de Castro. 2005. Qualitative and quantitative differences in peptides bound to HLA-B27 in the presence of mouse versus human tapasin define a role for tapasin as a size-dependent peptide editor. J. Immunol. 174: 7833-7844. (Pubitemid 40806292)
78. Williams, A. P., C. A. Peh, A. W. Purcell, J. McCluskey, and T. Elliott. 2002. Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520. (Pubitemid 34442576)
79. Peh, C. A., N. Laham, S. R. Burrows, Y. Zhu, and J. McCluskey. 2000. Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading. J. Immunol. 164: 292-299. (Pubitemid 30013002)
80. Braud, V. M., A. J. McMichael, and V. Cerundolo. 1998. Differential processing of influenza nucleoprotein in human and mouse cells. Eur. J. Immunol. 28: 625-635. (Pubitemid 28101740)
81. Street, M. D., T. Doan, K. A. Herd, and R. W. Tindle. 2002. Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology 106: 526-536. (Pubitemid 34994718)
82. Poland, G. A., Y. Sohni, M. Domanico, C. M. Kroning, S. R. DeGoey, M. Jimale, R. M. Jacobson, and S. B. Moore. 2001. High frequency of HLA-A*0103 allele in a Somali population. Hum. Immunol. 62: 197-200. (Pubitemid 32171660)
83. Sidney, J., B. Peters, N. Frahm, C. Brander, and A. Sette. 2008. HLA class I supertypes: a revised and updated classification. BMC Immunol. 9: 1-15.
84. Firat, H., S. Tourdot, A. Ureta-Vidal, A. Scardino, A. Suhrbier, F. Buseyne, Y. Rivìere, O. Danos, M.-L. Michel, K. Kosmatopoulos, and F. A. Lemonnier. 2001. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur. J. Immunol. 31: 3064-3074. (Pubitemid 32994558)
85. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class Irestricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5: 1026-1031. (Pubitemid 29439573)
86. Price, P., C. Witt, R. Allcock, D. Sayer, M. Garlepp, C. C. Kok, M. French, S. Mallal, and F. Christiansen. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167: 257-274. (Pubitemid 29178987) Médicale